Skip to content Skip to sidebar Skip to footer
New research offers hope for treating metabolic dysfunction-associated liver disease

New research offers hope for treating metabolic dysfunction-associated liver disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) — previously known as "non-alcoholic fatty liver disease" — affects about 25% of the global population. Its severe form, metabolic dysfunction-associated steatohepatitis (MASH), can lead to liver fibrosis and even liver failure. With only one approved treatment currently available, finding solutions for MASLD and MASH is crucial. MASLD and…

Read more

Common breast cancer therapies may speed up aging, study shows

Common breast cancer therapies may speed up aging, study shows

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has revealed that common breast cancer treatments, including chemotherapy, radiation, and surgery, may accelerate the biological aging process in breast cancer survivors.  The findings, published in the Journal of the National Cancer Institute, show that markers of cellular aging-;such as DNA damage response,…

Read more

Weekly injections of anti-obesity medications cost more than surgery

Weekly injections of anti-obesity medications cost more than surgery

The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) exceeds that of metabolic and bariatric surgery in less than a year, according to a recent analysis published in the journal Surgical Endoscopy. Researchers from USF Health Morsani College of Medicine in Tampa, FL compared the cumulative cost of pharmacotherapy with…

Read more

the Kick-ass Multipurpose WordPress Theme

© 2025 Kicker. All Rights Reserved.